Reducing Fraudulent and Imitation Drugs Act of 2006

S. 544 Patient Safety and Quality Improvement Act of 2005 S. 1227 Health Information Technology Act of 2005 S. 1223 Information Technology for Health Care Quality Act H.R. 3010 Labor/HHS/Education Appropriations Act S. 1418 Wired for Healthcare Quality Act H.R. 4157 Health Information Technology Promotion Act of 2006 Healthcare and RFID S. 2668 Reducing Fraudulent Imitation Drugs Act H.R. 4859 Federal Family Health Information Technology Act of 2006 H.R. 747 National Health Information Incentive Act of 2005 Health Information Technology H.R. 2234 21st Century Health Information Act of 2005 S. 16 Affordable Health Care Act

Client expense: $3,700,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Technology Administration, Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

S.109, Pharmaceutical Market Access Act of 2005, S.184, Safe IMPORT Act of 2005, Safe Importation of Medical Products and Other Rx Therapies Act of 2005, S.334, Pharmaceutical Market Access and Drug Safety Act of 2005, General discussion regarding drug reimportation, pharmaceutical distribution issues, recent issues with importation and adulterated drugs, ordering and dispensing technology related to hospital pharmacy and out-patient pharmacy activities, drug pricing, prescription drug discount cards, internet drug sales, S.1551, Protecting Free Trade in Pharmaceuticals Act of 2005, H.R.2345, Counterfeit Drug Enforcement Act of 2005, H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005, FY2005 Appropriations Act for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, S.2668, Reducing Fraudulent and Imitation Drugs Act of 2006, S.2582, Preserve Access to Affordable Generics Act, H.R.5156, Counterfeit Drug Prevention Act of 2006, S.2315, Methamphetamine Awareness and Prevention Act of 2006, H.R.4763, Methamphetamine Education Act, H.R.4829, Reducing Fraudulent and Imitation Drugs Act of 2006 H.R.314, Combat Meth Act of 2005, H.R.328, Pharmaceutical Market Access Act of 2005, S.103, Combat Meth Act of 2005,

Client expense: Not reported · Firm income: $40,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE